Novel protective effects of stem cell factor in a murine model of acute septic peritonitis: Dependence on MCP-1

American Journal of Pathology

Volumn 157, Issue 4, 2000, Pages 1177-1186

  Bone Larson, Cynthia L ^a   Hogaboam, Cory M ^a   Steinhauser, Matthew L ^a   Oliveira, Sandra H ^a   Lukacs, Nicholas W ^a   Strieter, Robert M ^a,b   Kunkel, Steven L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; STEM CELL FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; DRUG ACTIVITY; DRUG MECHANISM; MAST CELL; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; TREATMENT OUTCOME;

EID: 0033810107     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64633-0     Document Type: Article

References (36)

1. Increase in national hospital discharge survey rates for septicemia in the United States
2. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
3. Critical protective role of mast cells in a model of acute septic peritonitis
4. Requirement of endogenous tumor necrosis factor/cachetin for recovery from experimental peritonitis
5. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachetin
6. Stem cell factor is encoded at the S/locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor
7. The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo: Evidence that signaling through the c-kit receptor can induce expression of cellular function
8. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear ceils by recombinant human stem cell factor-kit-ligand in long-term culture
9. Reversible expansion of primate mast cell populations in vivo by stem cell factor
10. Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3, or IL-4
11. Stem cell factor is a chemotactic factor for human mast cells
12. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat
13. Co-expression of stem cell factor and c-kit in embryonic and adult liver
14. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells
15. Balance of inflammatory cytokines related to severity and mortality of murine sepsis
16. 4
17. Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: Role of interleukin-10 and monocyte chemoattractant protein 1
18. The c-kit receptor, stem cell factor, and mast cells: What each is teaching us about the others
19. The c-kit ligand, stem cell factor, promotes mast cell survival by suppression apoptosis
20. Stem cell factor has histamine-releasing activity in rat connective tissue-type mast cells
21. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock
22. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
23. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor
24. Interleukin-10 expression is autoregulated at the transcriptional level in human and murine Kupffer cells
25. Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained over-expression of tumor necrosis factor alpha messenger RNA in the regenerating liver
26. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6
27. Intrahepatic STAT-3 activation and acute phase gene expression predict outcome after CLP sepsis in rat
28. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: Evidence for an inhibitory loop involving endogenous IL-10
29. Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor
30. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice
31. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1b in mediating the production of IL-8 triggered by lipopolysaccharide
32. Endogenous IL-10 protects mice from death during septic peritonitis
33. JAKS and STATS: Biological implications
34. The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor
35. IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in promoters of selected genes
36. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins